ERICARD
0861.515.594 · rovalta.com · 21/09/2026
ERICARD
Overview
What does ERICARD do?
ERICARD is a Private limited company incorporated in 2003. Its registered office is in Herent.
3020 Herent · FlandreSee on map
Trend over 17 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Gross margin | 364,7 k € | -0.2% | 365,4 k € | +18.9% | 307,2 k € | -2.5% | 315 k € | -27.9% | 437 k € | +43.0% | 305,6 k € | +10.2% | 277,4 k € | +6.3% | 261,1 k € | +11.7% | 233,8 k € | +173% | 85,8 k € | -66.3% | 254,3 k € | +24.9% | 203,7 k € | -9.3% | 224,7 k € | +18.4% | 189,8 k € | -5.8% | 201,5 k € | +17.0% | 172,2 k € | -7.3% | 185,8 k € |
| EBITDA | 357,6 k € | -1.1% | 361,8 k € | +19.4% | 302,9 k € | -3.0% | 312,4 k € | -28.0% | 434 k € | +43.1% | 303,2 k € | +10.2% | 275 k € | +6.7% | 257,7 k € | +11.4% | 231,3 k € | +61.3% | 143,4 k € | -25.3% | 191,9 k € | -2.2% | 196,1 k € | -12.2% | 223,4 k € | +18.4% | 188,6 k € | -5.8% | 200,3 k € | +17.4% | 170,6 k € | -7.4% | 184,4 k € |
| Operating result | 310,2 k € | -3.3% | 320,7 k € | +20.5% | 266,2 k € | -4.0% | 277,3 k € | -28.2% | 386,3 k € | +36.2% | 283,7 k € | +13.6% | 249,8 k € | +10.1% | 226,9 k € | +13.4% | 200,1 k € | +70.6% | 117,3 k € | -29.1% | 165,5 k € | -4.6% | 173,5 k € | -13.2% | 199,8 k € | +45.8% | 137 k € | -21.8% | 175,2 k € | +17.5% | 149,1 k € | -10.1% | 165,8 k € |
| Net result | 232,5 k € | +1.6% | 228,9 k € | +32.0% | 173,3 k € | -6.1% | 184,6 k € | -29.3% | 261 k € | +44.3% | 180,9 k € | +16.0% | 155,9 k € | +28.4% | 121,4 k € | +3.0% | 117,9 k € | +108% | 56,8 k € | -49.4% | 112,2 k € | +3.2% | 108,8 k € | -16.9% | 130,9 k € | +33.3% | 98,2 k € | -3.4% | 101,6 k € | -5.5% | 107,6 k € | +4.7% | 102,8 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 1,7 M € | +16.0% | 1,5 M € | +18.7% | 1,2 M € | +16.5% | 1,1 M € | -18.1% | 1,3 M € | +76.3% | 727 k € | +12.7% | 645 k € | +31.9% | 489,1 k € | +33.0% | 367,7 k € | +47.2% | 249,9 k € | -4.3% | 261,1 k € | +75.4% | 148,9 k € | -65.7% | 434,1 k € | +43.2% | 303,2 k € | -40.0% | 505 k € | +20.0% | 420,9 k € | +34.3% | 313,3 k € |
| Total assets | 1,8 M € | +12.2% | 1,6 M € | +10.3% | 1,5 M € | +11.0% | 1,3 M € | -16.5% | 1,6 M € | +53.9% | 1 M € | +9.5% | 935,1 k € | +21.0% | 773 k € | +6.9% | 723,1 k € | +1.7% | 711 k € | -23.1% | 925 k € | +11.4% | 830 k € | +6.0% | 783,1 k € | -9.4% | 864,4 k € | +40.5% | 615,4 k € | +40.0% | 439,6 k € | +3.9% | 423,1 k € |
| Cash | 1,1 M € | +54.0% | 721,8 k € | +14.4% | 630,8 k € | +10.4% | 571,2 k € | -30.3% | 819,2 k € | +8.1% | 757,8 k € | +4.4% | 725,6 k € | +34.8% | 538,2 k € | +17.6% | 457,6 k € | +7.8% | 424,3 k € | -31.3% | 617,2 k € | +17.0% | 527,7 k € | +18.6% | 445 k € | -26.6% | 605,9 k € | +24.1% | 488,2 k € | +26.2% | 386,7 k € | -0.3% | 388 k € |
| Debts | 123,1 k € | -22.8% | 159,3 k € | -33.0% | 237,7 k € | -9.3% | 261,9 k € | -9.9% | 290,5 k € | -0.8% | 292,8 k € | +1.9% | 287,5 k € | +2.8% | 279,7 k € | -20.3% | 350,7 k € | -23.6% | 458,9 k € | -24.0% | 603,9 k € | -11.2% | 680,2 k € | +95.4% | 348,1 k € | -37.9% | 560,4 k € | +408% | 110,4 k € | +489% | 18,8 k € | -82.9% | 109,8 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 30/09/2025 · 1 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Dr. Els Van Essche, Reumatologie● Active | 0895.109.367 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 18 months | 12 months |
| Filing date | 23/04/2026 | 29/04/2025 | 17/04/2024 | 04/04/2023 | 29/04/2022 | 23/11/2020 |
| General meeting | 22/04/2026 | 24/04/2025 | 16/04/2024 | 30/03/2023 | 28/04/2022 | 21/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 22/04/2026 | 23/04/2026 | Dutch | |
| Micro model | 30/09/2024 | 24/04/2025 | 29/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 16/04/2024 | 17/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 30/03/2023 | 04/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 28/04/2022 | 29/04/2022 | Dutch | |
| Micro model | 31/03/2020 | 21/11/2020 | 23/11/2020 | Dutch | |
| Micro model | 31/03/2019 | 30/09/2019 | 29/10/2019 | Dutch | |
| Micro model | 31/03/2018 | 28/09/2018 | 25/10/2018 | Dutch | |
| Micro model | 31/03/2017 | 29/09/2017 | 27/10/2017 | Dutch | |
| Abridged model | 31/03/2016 | 30/09/2016 | 25/10/2016 | Dutch | |
| Abridged model | 31/03/2015 | 25/09/2015 | 05/10/2015 | Dutch | |
| Abridged model | 31/03/2014 | 26/09/2014 | 20/10/2014 | Dutch | |
| Abridged model | 31/03/2013 | 30/09/2013 | 28/10/2013 | Dutch | |
| Abridged model | 31/03/2012 | 28/09/2012 | 22/10/2012 | Dutch | |
| Abridged model | 31/03/2011 | 30/09/2011 | 21/10/2011 | Dutch | |
| Abridged model | 31/03/2010 | 24/09/2010 | 21/10/2010 | Dutch | |
| Abridged model | 31/03/2009 | 25/09/2009 | 06/10/2009 | Dutch | |
| Abridged model | 31/03/2008 | 26/09/2008 | 22/10/2008 | Dutch | |
| Abridged model | 31/03/2007 | 29/09/2007 | 30/11/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 30/09/2025 · 1 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates17/04/2020WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares13/04/2018KAPITAAL - AANDELEN
- Capital / shares11/04/2014KAPITAAL - AANDELEN
- Registered office22/12/2008MAATSCHAPPELIJKE ZETEL
- Other14/11/2003RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025232,5 k €↑
- 2024Annual accounts 2024228,9 k €↑
- 2023Annual accounts 2023173,3 k €↓
- 2022Annual accounts 2022184,6 k €↓
- 2021Annual accounts 2021261 k €↑
- 2018Annual accounts 2018180,9 k €↑
- 2017Annual accounts 2017155,9 k €↑
- 2016Annual accounts 2016121,4 k €↑
- 2015Annual accounts 2015117,9 k €↑
- 2014Annual accounts 201456,8 k €↓
- 2013Annual accounts 2013112,2 k €↑
- 2012Annual accounts 2012108,8 k €↓
- 2011Annual accounts 2011130,9 k €↑
- 2010Annual accounts 201098,2 k €↓
- 2009Annual accounts 2009101,6 k €↓
- 2008Annual accounts 2008107,6 k €↑
- 2007Annual accounts 2007102,8 k €
- 05/11/2003IncorporationPrivate limited company